Skip to main content
Catherine Broome, MD, Hematology, Washington, DC

Catherine M Broome MD

Hematology•Washington, DC

Clotting Disorder, Hemophilia & Bleeding Disorder

Associate Professor, Medicine, Georgetown University School of Medicine

Join to View Full Profile

  • 3700 Reservoir RdLombardi Cancer Center Podium DWashington, DC 20007

Dr. Broome is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Broome's Full ProfileAlready have an account?

Clinical Expertise

  • Hematologic oncology, Autoimmune hemolytic anemia, Complement deficiencies, Immune thrombocytopenic purpura, Hemolytic-uremic syndrome, Bleeding disorders, Anemia

Education & Training

  • George Washington University
    George Washington UniversityFellowship, Hematology and Medical Oncology, 1988 - 1991
  • Prisma Health/University of South Carolina SOM Greenville (Greenville)
    Prisma Health/University of South Carolina SOM Greenville (Greenville)Residency, Internal Medicine, 1985 - 1988
  • LSU School of Medicine in Shreveport
    LSU School of Medicine in ShreveportClass of 1985

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1989 - 2028
  • VA State Medical License
    VA State Medical License 1993 - 2022
  • MD State Medical License
    MD State Medical License 2010 - 2020
  • SC State Medical License
    SC State Medical License 1986 - 1993
  • LA State Medical License
    LA State Medical License 1985 - 1989
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2013, 2015, 2017
  • CMS Meaningful Use Stage Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013, 2015, 2017
  • CMS Meaningful Use Stage Stage 2 Certification MEDSEEK Empower, SymphonyCare, LLC, 2013, 2015, 2017

Publications & Presentations

PubMed

Abstracts/Posters

  • Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicent...
    Catherine M. Broome, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO (Sutimlimab-Jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology (ASH) Annual Meeting
    Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO (Sutimlimab-Jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology (ASH) Annual MeetingDecember 9th, 2025
  • Researchers Find Drug Effective to Treat Autoimmune Blood Disorder
    Researchers Find Drug Effective to Treat Autoimmune Blood DisorderDecember 12th, 2022
  • After One Week, Efgartigimod Helps 38% of ITP Patients Achieve Platelet Counts to Avoid Bleeding
    After One Week, Efgartigimod Helps 38% of ITP Patients Achieve Platelet Counts to Avoid BleedingDecember 11th, 2022

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Catherine Broome, Dr. Catherine Broome, MD, Dr. C Broome, Dr. Catherine M Broome